Life ScienceCompany
Brooklyn ImmunoTherapeutics M&A Summary
Brooklyn ImmunoTherapeutics has acquired 3 companies, including 2 in the last 5 years.
Brooklyn ImmunoTherapeutics’ largest acquisition to date was in 2021, when it acquired Novellus for $125M. Brooklyn ImmunoTherapeutics has acquired in 3 different US states. The Company’s most targeted sectors include life science (67%) and media (34%).
Brooklyn ImmunoTherapeutics Business Overview
Where is Brooklyn ImmunoTherapeutics headquartered?
Brooklyn ImmunoTherapeutics is headquartered in Brooklyn, New York.
What sector is Brooklyn ImmunoTherapeutics in?
Brooklyn ImmunoTherapeutics is a life science company.
M&A Summary
-
M&A Total Activity3
- M&A Buy Activity3
- Total Sectors Invested 2
- Total Countries Invested 1
- M&A Buy/Sell Connections 1
- M&A Advisors 1